Below you will find a list of Sedulo's case studies. In adherence to strict Non-Disclosure Agreements, Sedulo is unable to disclose identifiable information regarding our clients.
A leading pharmaceutical company partnered with Sedulo Group to build a continuous competitive intelligence program tracking innovators, biosimilars, and emerging therapies across the rapidly evolving insulin market. The engagement combined ongoing competitor monitoring, primary intelligence, and quarterly landscape reporting to support stronger portfolio decisions and confident preparation for new market entrants.
A digital commerce solutions provider partnered with Sedulo to uncover competitor GTM strategies, pricing, and product differentiators, empowering clearer positioning and strategic decision-making.
A global pharmaceutical company partnered with Sedulo to gain continuous visibility into competitive dynamics across four therapeutic areas. The result was faster BD scouting, clearer portfolio prioritization, and more confident strategic decisions.
Sedulo supported a global data standards organization with a targeted sizing analysis that combined primary expert interviews and rigorous secondary research to identify and prioritize high-growth market opportunities. The engagement delivered clear investment guidance and actionable insights to support confident expansion into new sectors.
A biopharma leader partnered with Sedulo on a multi-year competitive intelligence program to connect early clinical signals with commercial strategy. The engagement delivered continuous insights across 10 rare disease areas, enabling faster decisions, earlier warnings, and confident portfolio planning.
The Situation A global technology company with a stronghold in the enterprise segment was seeking to strengthen its performance in the small-to-mid-market (SMM) space. While large enterprise deals followed expected patterns, outcomes in the SMM segment were less predictable, revealing a need to better understand the buying behaviors and competitive dynamics influencing those decisions. Leadership engaged Sedulo Group to uncover: …
Facing intensifying competition in the metabolic therapeutics arena, the pharma leader needed clear foresight into biosimilar threats, innovation pipelines, and competitor launch tactics. Through early-warning monitoring, primary intelligence, and deep landscape reporting, we helped them anticipate market shifts, align internal decision-makers, and fortify their leadership ahead of emerging disruptions.
When a rising competitor began making bold AI-centric claims, our client knew words weren’t enough, but facts were missing. Through buy-side research, we exposed that behind the AI messaging was an offshore manual data entry engine, arming the client with truthful insight to sharpen positioning, arm sales, and challenge false narratives.
A top pharmaceutical company partnered with Sedulo Group to leverage pharma competitive intelligence and outmaneuver competitors in a high-stakes product launch.
Entering a new market without the right intelligence is a costly risk. Learn how Sedulo Group equips companies with deep competitor, customer, and market insights to build confident, data-driven market entry strategies
